Growth hormone deficiency and replacement in patients with treated Cushing's Disease, prolactinomas and non-functioning pituitary adenomas: effects on body composition, glucose metabolism, lipid status and bone mineral density.
BACKGROUND/AIMS: This study was designed to determine whether previous Cushing's disease (CD) or prolactinoma (PRL) could exert adverse effects additional to those of growth hormone (GH) deficiency as a consequence of variable degrees of prior hypogonadism or hypercatabolism. We report the effe...
主要な著者: | Colson, A, Brooke, A, Walker, D, Besser, G, Chew, S, Grossman, AB, Jenkins, P, Drake, WM, Monson, J |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
2006
|
類似資料
-
Role of fasting plasma glucose, glycated haemoglobin and homeostatic model assessment in the detection of glucose intolerance in adult hypopituitary patients during growth hormone replacement therapy.
著者:: Colson, A, 等
出版事項: (2008) -
Prolactinomas, Cushing's disease and acromegaly: debating the role of medical therapy for secretory pituitary adenomas
著者:: Bonert Vivien S, 等
出版事項: (2010-05-01) -
Safety of GH replacement in hypopituitary patients with nonirradiated pituitary and peripituitary tumours.
著者:: Chung, T, 等
出版事項: (2008) -
Tumour surveillance imaging in patients with extrapituitary tumours receiving growth hormone replacement.
著者:: Chung, T, 等
出版事項: (2005) -
Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumors.
著者:: Korbonits, M, 等
出版事項: (1998)